Evaluation of the physico-chemical stability of the adapted oral pharmaceutical form of mycophenolate mofetil
DOI:
https://doi.org/10.30968/rbfhss.2024.154.1124Abstract
Objective: To evaluate the physicochemical stability of the adapted oral suspension of mycophenolate mofetil tablets developed by a university hospital in Paraná, in order to determine the concentration of the active ingredient present in the oral suspension over time, assess the homogeneity of the drug concentration during the administration of the doses and establish a shelf life consistent with the stability of the adapted pharmaceutical form. Method: Mycophenolate mofetil tablets were used to make suspensions in two different concentrations - 50 mg/mL and 100 mg/mL - using sorbitol and water as vehicles (1:1) and adding a flavoring agent. The chromatographic analysis of the samples was carried out at times (T): T0h, T24h, T48h, T120h and T168h. The chromatographic conditions used for high-performance liquid chromatography were adapted from the United States Pharmacopeia. Results: The average relative standard deviation of the three batches analyzed at each time and concentration ranged from 6 to 18%, establishing an acceptable variability in the data obtained, but signaling the inhomogeneity of the active in the suspension. In the chromatographic analysis, the drug concentration values obtained in the formulations were satisfactory for all the times analyzed, with the values for T0h, T24h, T48h, T120h and T168h being 100%, 99.3%, 97.2%, 106.6% and 96.8% respectively. No physical changes were observed during the análisis period. The formulation showed physicochemical stability in an amber glass bottle, protected from light and at room temperature for 7 days. Conclusion: It was possible to validate the stability of the proposed formulations for seven days at room emperature and in an amber glass bottle. It is important to develop further studies on oral liquid formulations adapted from mycophenolate mofetil tablets.
Downloads
References
DE OLIVEIRA COSTA, Andre Lima. Éster 2-morfolinoetil e sal sódico do ácido micofenólico: desenvolvimento e validação de métodos analíticos para o controle de qualidade de matéria-prima e comprimidos. 2009. Disponível em: http://hdl.handle.net/1843/FARD-82TLBV. Acesso em 11 dez. 2023.
Brasília: CONITEC, 2016. BRASIL. Relatório de recomendação - Imunossupressores pós transplante de medula óssea. Brasília: Ministério da Saúde. Disponível em: https://www.gov.br/saude/pt-br/composicao/conjur/demandas-judiciais/notas--tecnicas/notas-tecnicas-medicamentos/notas-tecnicas/m/micofenolato.pdf. Acesso em 05 fev. 2024.
DA SILVA, Luna Clara França; MARTINS, Carolina Lopes; TOFANI, Andrea Almeida. Perfil de Utilização de Imunossupressores para Profilaxia de Doença Enxerto versus Hospedeiro em Pacientes Submetidos ao Transplante de Células-Tronco Hematopoiéticas. Revista Brasileira de Cancerologia, v. 65, n. 2, 2019. Doi: 10.32635/2176-9745.RBC.2019v65n2.148
EZQUER‐GARIN, Carlos; FERRIOLS‐LISART, Rafael; ALÓS‐ALMIÑANA, Manuel. Stability of mycophenolate mofetil in polypropylene 5% dextrose infusion bags and chemical compatibility associated with the use of the Equashield® closedsystem transfer device. Biomedical Chromatography, v. 33, n. 7, p. e4529, 2019. Doi: 10.1002/bmc.4529
BRASIL, Ministério da Saúde. Nota Técnica nº 304/2013. Micofenolato de Mofetila e Micofenolato de Sódio. Ministério da Saúde, 2013. Disponível em: https://www.gov.br/saude/pt-br/composicao/conjur/demandas-judiciais/notas-tecnicas/notas-tecnicas-medicamentos/notas-tecnicas/m/micofenolato.pdf. Acesso em 05 fev. 2024.
MARINHO, Rafaella Nayara Andrade; CABRAL, CÍNTIA HATSUE KITAYAMA. Estudo de adaptações de formulações farmacêuticas em um hospital universitário pediátrico. Rev Bras Farm Hosp Serv Saude, v. 3, 2014.
SILVA, Márcio Robert Mattos da et al. Preparation of extemporaneous oral liquid in the hospital pharmacy. Brazilian Journal of Pharmaceutical Sciences, v. 56, 2020. Doi:10.1590/s2175-97902019000418358
UNITED States Pharmacopeia - National Formulary. 35ª edição. volume 2. Rockville, 2012. Disponível em: http://www.usp.org/. Acesso em 22 nov. 2023.
SEEBACHER, Gernot et al. A simple HPLC method for monitoring mycophenolic acid and its glucuronidated metabolite in transplant recipients. 1999. Doi: https://doi.org/10.1515/CCLM.1999.067
ANVISA. Agência Nacional de Vigilância Sanitária. Farmacopeia Brasileira, volume 2. 6ª Ed. Brasília, 2019. Disponível em: https://www.gov.br/anvisa/pt-br/assuntos/farmacopeia/farmacopeia-brasileira. Acesso em 11 dez. 2023.
ANAIZI, Nasr H.; SWENSON, Chad F.; DENTINGER, Paul J. Stability of mycophenolate mofetil in an extemporaneously compounded oral liquid. American journal of health-system pharmacy, v. 55, n. 9, p. 926-929, 1998. Doi: 10.1093/ajhp/55.9.926
FAHIMI, Fanak et al. Physical and chemical stability of mycophenolate mofetil (MMF) suspension prepared at the hospital. Iranian Journal of Pharmaceutical Research: IJPR, v. 11, n. 1, p. 171, 2012.
DA FARMACOPEIA, Coordenação et al. Formulário nacional da farmacopeia brasileira 2ª edição. 2012. Disponível em: http://bibliotecadigital.anvisa.ibict.br/jspui/handle/anvisa/834. Acesso em 09 fev. 2024.
USP. General Chapter <795> Pharmaceutical compounding — nonsterile preparations. United States Pharmacopeia: Rockville, MD, EUA, 2010.
LENHART, Adrienne; CHEY, William D. A systematic review of the effects of polyols on gastrointestinal health and irritable bowel syndrome. Advances in nutrition, v. 8, n. 4, p. 587-596, 2017. Disponível em: https://www.sciencedirect.com/science/article/pii/S2161831322006901?via%3Dihub.Acesso em 12 out. de 2024.
FERNÁNDEZ-BAÑARES, F.; ESTEVE, M.; VIVER, Josep M. Fructose-sorbitol malabsorption. Curr Gastroenterol Rep., v. 11, n. 5, p. 368-374, 2009. Disponível em: https://link-springer-com.ez22.periodicos.capes.gov.br/article/10.1007/s11894-009-0056-9. Acesso em 12 out. de 2024.
GOTFRIED, J. Diarreia. Manual MSD, 2022. Disponível em: https://www.msdmanuals.com/pt/profissional/dist%-C3%BArbios-gastrointestinais/sintomas-dos-dist%C3%BArbios-gastrointestinais/diarreia. Acesso em 12 out. de 2024.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Serlf-archiving policy
This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.